Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target

Laura M Rozan1, Wafik S El-Deiry

  • 1Department of Medicine (Hematology/Oncology), Institute for Translational Medicine and Therapeutics and Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Cancer Biology & Therapy
|September 14, 2006
PubMed

Insights

Tumor necrosis factor receptor associated factor 4 (Traf4) is upregulated in breast tumors. Traf4 interacts with beta-catenin, potentially influencing transcription and protein stability, and its function is explored through protein interaction studies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor receptor associated factor 4 (Traf4) mRNA is upregulated in breast tumors.
  • Traf4 was previously identified as a p53 target gene, with overexpression inhibiting colony formation.
  • Basal Traf4 expression is not solely dependent on p53.

Purpose of the Study:

  • To identify Traf4-interacting proteins and elucidate its function.
  • To investigate Traf4's role in beta-catenin regulation.
  • To explore Traf4's interactions in a physiological context.

Main Methods:

  • Yeast two-hybrid screens with full-length Traf4 bait.
  • Coimmunoprecipitation followed by mass spectrometry.
  • Mammalian cell-based interaction studies.

Main Results:

  • Yeast two-hybrid identified beta-catenin, GRIM19, PSMC3, p62, and dynamin as Traf4 interactors.
  • Traf4 enhances beta-catenin-related transcription and protects beta-catenin from p53-mediated degradation.
  • Mass spectrometry identified Eg5, PRMT5, and MYH-9 as novel Traf4 interactors in mammalian cells.

Conclusions:

  • Traf4 interacts with multiple proteins, including beta-catenin, suggesting diverse functional roles.
  • Traf4 influences beta-catenin stability and transcriptional activity.
  • Novel Traf4-interacting proteins were identified, expanding the understanding of Traf4's molecular network.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...